Radical fertility preserving surgery of gynaecological malignancies – five-year-old file

Česká verzia

Authors: Michal Felsinger ; Luboš Minář ; Vít Weinberger ; R. Hudeček
Authors place of work: Gynekologicko-porodnická klinika LF MU a FN, Brno přednosta prof. MUDr. P. Ventruba, DrSc., MBA
Published in the journal: Ceska Gynekol 2015; 80(5): 339-344

Summary

Objective:
Analysis of radical fertility preserving surgery, oncogynaecological treatment including their pregnancy effort.

Design:
Prospective study.

Setting:
Department of Obstetrics and Gynaecology, Masaryk University and Faculty Hospital Brno.

Methods:
The group of 13 patients in age fifteen to thirty-six, who underwent radical fertility preserving surgery of oncogynecological tumors (cervix, ovarium), 9 patients with ovarian cancer and 4 patients with carcinoma of cervix.

Results:
Histology showed seven times ovarial epithelial carcinoma, twice nonepithelial ovarial carcinoma, twice spinocelular cervical carcinoma, one adenosquamous and one lymfoepithelioma like carcinoma. We reported lymphocele as the most often postoperative complication by five patients with ovarial carcinoma, lymphoedema of lower limbs in one case and one of them complicated by bilateral hydronephrosis. After surgery procedures of cervical carcinoma, there was a stenosis of cervical canal with postoperative correction. In one case there was provided vaginal revision of cervix followed by embolisation of uterine arteries because of heavy bleeding in early postoperative period. After two years follow up, there are 12 patients in remission. There were four patients with fertlity plan, two with ovarial carcinoma, two with cervical carcinoma. The first group describes two pregnancies – one misscariage and one spontaneus labour in the date of delivery. There were 4 pregnancies in two patients wit cervical carcinoma. One patient has an intrapartal cesarean section because of scarring of the cervix after the operation. Next patients has two labours in due date, three labours in 34–37th week of pregnancy and one misscariage in 23 week of pregnancy. One patient has ovarial cancer during pregnancy, so the radical fertility preserving surgery was done after delivery.

Conclusion:
Methods and procedures of surgery with fertility preserving goals in our oncogynecological centre are in concordance with actual knowledge of medicine and respect oncological safety of patients with malignancies, who currently wish for fertility preserving treatment. Presented group of patients is relatively small, but results of oncological treatment and fertility plan demonstrate rightfulness of this tretament.

Keywords:
radical fertility preserving surgery, simple vaginal trachelectomy, adnexectomy, lymphadenectomy

Zdroje

1. Bats, AS., Buénerd, A., Querleu, D., et al. Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: a prospective, multicenter study. Gynecol Oncol, 2011, 123(2), p. 230–235. doi: 10.1016/j.ygyno.2011.08.010. Epub 2011 Sep 3.

2. Cibula, D., Abu-Rustum, NR., Dusek, L., et al. Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol Oncol, 2012, 124(3), p. 496–501. doi: 10.1016/j.ygyno.2011.11.037. Epub 2011 Nov 25.

3. Cibula, D., Oonk, MH., Abu-Rustum, NR. Sentinel lymph node biopsy in the management of gynecologic cancer. Curr Opin Obstet Gynecol, 2015, 27(1), p. 66–72. doi: 10.1097/GCO.0133.

4. Cibula, D., Petruželka, L., et al. Onkogynekologie. Praha: Grada Publishing, 2009, 614 s. ISBN 978-80-247-2665-6.

5. Cibula, D., Zikan, M., Dusek, L., Majek, O. Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis. Expert Rev Anticancer Ther, 2011, 11(8), p. 1197–1207. doi: 10.1586/era.11.38.

6. Dusek, L., Muzik, J., Maluskova, D., et al. Cancer incidence and mortality in the Czech Republic. Klin Onkol, 2014, 27(6), p. 406–423.

7. Eiriksson, L., Covens, A. Sentinel lymph node mapping in cervical cancer: the future? BJOG, 2012, 119, p. 129–133. doi: 10.1111/j.1471-0528.2011.03134.x.

8. Felsingerová, Z., Minář, L., Weinberger, V. Incidence a terapie lymfocyst po provedené systematické pánevní a paraaortální lymfadenektomii. Čes Gynek, 2014, 79, 5, s. 388–392.

9. Fischerova, D., Cibula, D. Ultrasound in gynecological cancer: is it time for re-evaluation of its uses? Curr Oncol Rep, 2015, 17(6), p. 28. doi: 10.1007/s11912-015-0449-x.

10. Fischerova, D. Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review. Ultrasound Obstet Gynecol, 2011, 38(3), p. 246–266.

11. Fruscio, R., Corso, S., Ceppi, L., et al. Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series. Ann Oncol, 2013, 24(1), p. 138–144. doi: 10.1093/annonc/mds241. Epub 2012 Sep 3.

12. Halaska, M., Robova, H., Pluta, M., Rob, L. The role of trachelectomy in cervical cancer. Ecancermedicalscience, 2015, 9, p. 506. doi: 10.3332/ecancer.2015.506. eCollection 2015.

13. Minář, L. Fertilitu zachovávající terapie gynekologických malignit. Čes Gynek, 2009, 74, 6 s. 420–427.

14. Minář, L., Ivanová, Z., Jandáková, E. Ovariální epiteliální nádory v adolescentním věku. Čes Gynek, 2014, 79, 2 s. 98–102.

15. Minář, L., Weinberger, V., Kysela P. Komplikace radikálních onkogynekologických operací. Čes Gynek, 2010, 75(4), p. 346–352.

16. Rob, L., Robova, H., Chmel, R., et al. Surgical options in early cervical cancer. Int J Hyperthermia, 2012, 28(6), p. 489–500. doi: 10.3109/02656736.2012.675116. Epub 2012 Jun 12.

17. Rob, L., Skapa, P., Robova, H. Fertility-sparing surgery in patients with cervical cancer. Lancet Oncol, 2011, 12(2), p. 192–200. doi: 10.1016/S1470-2045(10)70084-X. Epub 2010 Jul 8.

18. Robová H., Rob, L,. Pluta, M., et.al. Guideline gynekologických zhoubných nádorů: Standard-komplexní léčba časných stadií zhoubných nádorů děložního hrdla. Onkogynekologie [online]. 15.6.2013 [cit. 2014-02-28]. Dostupné z: http://www.onkogynekologie.com/wp-content/uploads/2011/03/Guideline-C53_2013.pdf.

19. Sehnal, B., Driák, D., Kmonícková, E., et al. Současná klasifikace zhoubných nádorů v onkogynekologii – část II. Čes Gynek, 2011, 76(5), p. 360–366.

20. Sláma, J. Pooperační sledování po konzervativním ošetření prekanceróz děložního hrdla. Čes Gynek, 2011, 76(5), p. 339–342.

21. Weinberger, V., Cibula, D., Zikán, M. Lymphocele: prevalence and management in gynecological malignancies. Expert Rev Anticancer Ther, 2014, 14(3), p. 307–317. doi: 10.1586/14737140.2014.866043. Epub 2014 Feb 3.

22. Weinberger, V., Dvořák, M., Haaková, L., et al. Ultrazvukový staging karcinomu děložního hrdla – Návrh standardního postupu. Čes Gynek, 2014, 79, 6, s. 447–455.

23. Weinberger, V., Minář, L. Diagnostics of malign ovarian tumors by ultrasound and CA 125 – our experience. Intern J Gynecol Cancer, 2013, s. 494 –1759. ISSN 1048 -891X.

24. Zikán, M., Cibula, D., Fischerová, D., et al. Guideline gynekologických zhoubných nádorů: Standard – komplexní léčba ovariálních epiteliálních zhoubných nádorů. Onkogynekologie. [online]. 15.6.2013 [cit. 2014-02-28]. Dostupné z: http://www.onkogynekologie.com/wp-ontent/uploads/2011/03/Guideline_C56_Epit_2013.pdf

25. Zikán, M. Doporučení genetické testace u pacientek s gynekologickým zhoubným nádorem. Čes Gynek, 2015, 80(2), p. 97–103.